https://pressroom.prlog.org/Datavagyanik/ About Datavagyanik.com - "Healthcare involves the prevention, diagnosis, treatment, and management of illness to promote overall health and well-being." https://www.prlog.org/13091805-collagen-peptide-supplements-market-to-surpass-690-million-by-2025.html Collagen Peptide Supplements Market to Surpass $690 Million by 2025, Driven by 15% CAGR Through 2032Wed, 06 Aug 2025 10:08:12 GMT https://www.prlog.org/13091352-monoclonal-antibodies-in-osteoporosis-treatment-market-to-reach-4250-million-by-2025.html Monoclonal Antibodies in Osteoporosis Treatment Market to Reach $4,250 Million by 2025, Driven by Aging Population and Innovative TherapiesWed, 06 Aug 2025 09:01:02 GMT https://www.prlog.org/13090227-sclerostin-inhibitors-market-to-reach-1-98-billion-by-2032.html SCLEROSTIN INHIBITORS Market to Reach $1.98 Billion by 2032, Driven by Osteoporosis Therapies and Biologic AdvancementsTue, 29 Jul 2025 09:06:17 GMT https://www.prlog.org/13090039-omega-3-based-eye-supplements-market-to-reach-1-3-billion-by-2032.html OMEGA-3 Based Eye Supplements Market to Reach $1.3 Billion by 2032, Driven by Rising Eye Health Awareness and Aging PopulationTue, 29 Jul 2025 08:59:54 GMT https://www.prlog.org/13088414-long-acting-injectable-antipsychotics-market-to-reach-480-million-by-2025.html LONG-ACTING INJECTABLE ANTIPSYCHOTICS Market to Reach $480 Million by 2025, Projected to Grow at 8% CAGR Through 2032Fri, 18 Jul 2025 09:59:16 GMT https://www.prlog.org/13087998-alpha-emitter-radiopharmaceuticals-market-to-reach-1650-million-by-2025.html ALPHA-EMITTER RADIOPHARMACEUTICALS Market to Reach $1,650 Million by 2025, Driven by Rising Oncology Applications and Precision Medicine TrendsThu, 17 Jul 2025 09:32:17 GMT